6 Breathnach SM. Drug reactions. In: Burns T, Breathnach S, Cox N, et al. eds. Rook’s Textbook of Dermatology, Vol. 2, 7th edn. Oxford, UK: Blackwell Science, 2004: 73.1–73.180. 7 Bialy-Golan A, Brenner S. Penicillamine-induced bullous dermatoses. J Am Acad Dermatol 1996; 35: 732–742. 8 Kaplan RP, Potter TS, Fox JN. Drug-induced pemphigus related to angiotensin-converting enzyme inhibitors. J Am Acad Dermatol 1992; 26: 364–366. 9 Civatte J, Duterque M, Blanchet P, et al. Deux cas de pemphigus superficial induit par le pyritinol. Ann Damatol Venereol 1978; 105: 573–577. 10 Alinovi A, Benoldi O, Manganelli P. Pemphigus erythematosus induced by tiopronin. Acta Derm Venereol (Stockh) 1982; 62: 452–454. 11 Jaffe IA. Adverse effects profile of sulfhydryl compounds in man. Am J Med 1986; 80: 471–476. 12 Papacharalambous V, Pramatarov K, Tsankov N. Development of pemphigus in a patient with rheumatoid arthritis during a course of gold therapy. Eur J Dermatol 1997; 7: 65–66. 13 Fellner MJ, Mark AS. Penicillin and ampicillin-induced pemphigus vulgaris. Int J Dermatol 1980; 19: 392–393. 14 Lee CW, Lim JH, Kang HJ. Pemphigus foliaceus induced by rifampicin. Br J Dermatol 1984; 111: 619–622. 15 Anadolu RY, Birol A, Bostanci S, et al. A case of pemphigus vulgaris possibly triggered by quinolones. J Eur Acad Dermatol Venereol 2002; 16: 152–153. 16 Wolf R, Dechner E, Ophir J, et al. Cephalexin: A non-thiol drug that may induce pemphigus vulgaris. Int J Dermatol 1991; 30: 213–215. 17 Brenner S, Bialy-Golan A, Crost N. Dipyrone in the induction of pemphigus. J Am Acad Dermatol 1997; 36: 488–490. 18 Ramseur WI, Richards F, Duggan DB. A case of fatal pemphigus vulgaris in association with beta interferon and interleukin-2 therapy. Cancer 1989; 63: 2005–2007. 19 Niizeki H, Inamoto N, Nakamura K, et al. A case of pemphigus foliaceus after interferon alpha-2a therapy. Dermatology 1994; 189: 129–130. 20 Goddard W, Lambert D, Gavanou J, et al. Pemphigus acquit apres traitement par l’association propranolol-meprobamate. Ann Dermatol Venereol 1980; 107: 1213–1216. 21 Dourmishev AL, Rahman MA. Phenobarbital-induced pemphigus vulgaris. Dermatologica 1986; 173: 256–258. 22 Fellner MJ, Winiger J. Pemphigus erythemalosus and heroin addiction. Int J Dermatol 1978; 17: 308–311. 23 Paterson AJ, Lamey PJ, Lewis MA, et al. Pemphigus vulgaris precipitated by glibenclamide therapy. J Oral Pathol Med 1993; 22: 92–95. 24 Demento FJ, Grover RW. Acantholytic herpetiform dermatitis. Arch Dermatol 1973; 107: 883–887. 25 Kim SC, Won JH, Ahn SK. Pemphigus foliaceus induced by nifedipine. Acta Derm Venereol (Stockh) 1993; 73: 210–211. 26 Martin RI, Mcsweeny GW, Schneider J. Fatal pemphigus vulgaris in a patient taking piroxicam. N Engl J Med 1983; 309: 795–796. 27 Gooptu C, Litt1ewood TJ, Frith P, et al. Paraneoplastic pemphigus: an association with fludarabine? Br J Dermatol 2001; 144: 1255–1261. 28 Patterson CR, Davies MG. Carbamazepine-induced pemphigus. Clin Exp Dermatol 2003; 28: 98–99. 29 Lin R, Ladd DJ Jr, Powell DJ, et al. Localized pemphigus foliaceus induced by topical imiquimod treatment. Arch Dermatol 2004; 140: 889–890.
[1]
D. Tsiftsis,et al.
Treatment of advanced malignant eccrine poroma with locoregional chemotherapy
,
2005,
The British journal of dermatology.
[2]
P. Butler,et al.
Unusual metastatic spread of a malignant eccrine poroma.
,
2002,
Dermatology online journal.
[3]
P. H. Mckee,et al.
Eccrine Porocarcinoma (Malignant Eccrine Poroma): A Clinicopathologic Study of 69 Cases
,
2001,
The American journal of surgical pathology.
[4]
E. Schöpf,et al.
Metastasizing Porocarcinoma of the Head with Lethal Outcome
,
1999,
Dermatology.
[5]
F. Recchia,et al.
Malignant Metastatic Eccrine Poroma: Proposal for a New Therapeutic Protocol
,
1997,
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[6]
H. Mori,et al.
Malignant eccrine poroma with multiple visceral metastases: report of a case with autopsy findings
,
1996,
Journal of cutaneous pathology.
[7]
B. Guillot,et al.
Metastasizing eccrine porocarcinoma: report of a case and review of the literature.
,
1996,
Journal of the American Academy of Dermatology.
[8]
P. Harari,et al.
The role of radiotherapy in the treatment of malignant sweat gland neoplasms
,
1990,
Cancer.
[9]
J. Breau,et al.
Sweat gland carcinoma with bone and visceral metastases. Prolonged complete remission lasting 16 months as a result of chemotherapy
,
1987,
Cancer.
[10]
D. Miles,et al.
Clinical case Metastatic eccrine porocarcinoma: Response to docetaxel (Taxotere) chemotherapy
,
2005
.